Abstract
Background Dementia screening tools typically involve face-to-face cognitive testing. Indeed, this introduces an increasing burden on the clinical staff, particularly in low-resource settings. The objective of our study is to develop an integrated online platform for efficient dementia screening, using a brief and cost-effective assessment.
Methods We used the Longitudinal Ageing Study in India dataset (LASI-DAD, n=2528) to predict dementia diagnosis based on the Clinical Dementia Rating (CDR). Using feature selection algorithms and principal component analysis (PCA), we identified key predictive features. We compared the performance of six machine learning (ML) classifiers that were trained on the 42 selected features (full model) and the two components identified by PCA (minimal model). The best-performing model was selected for our web platform.
Results Selected features mapped onto two distinct, interpretable domains: a cognitive domain and an informant domain. The first two principal components cumulatively explained 90.2% of the variance and included questions from the Mini-Mental State Exam (MMSE) and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Classifiers trained on the minimal model performed on par with the full model, with Support Vector Machine performing best (93.4%). The model did not reliably predict Parkinson’s disease (67% accuracy) or stroke (53.1% accuracy), suggesting dementia specificity. The respective questions from MMSE and IQCODE (27 items) were incorporated into our online platform.
Conclusion We built an online platform enabling end-to-end screening for dementia from assessment to prediction, based on patient and caregiver reports. Web App code is available at GitHub: https://github.com/sanjaysinghrathi/READi-Dem & Web App link is available at Web Page: https://researchmind.co.uk/readi-dem. For the convenience of researchers, a video summarizing our work is also accessible on the Web App Page and YouTube Link.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would like to acknowledge the DEMON Network for their kind and continuous support with this research from forming the idea in the DEMON NeuroHack 2022 until the dissemination of this research. Our special thanks go to the University of Exeter for the Alan Turing grant to fund this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://lasi-dad.org
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵** This author designated as project incharge.
All authors were supported by a pilot Alan Turing grant awarded by the DEMON Network and The Alan Turing Institute
Data Availability
All data used for ML model are available online at https://lasi-dad.org
